NC
CERE

NinePointTwo Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

NinePointTwo Capital’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,151
Closed -$259K – 337
2023
Q2 		$259K Buy
+8,151
New +$259K 0.1% 110